DUALITYBIO-B(09606),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09606 DUALITYBIO-B

Trading 07-24 13:37:45

233.400

-1.400

-0.60%

High243.000	Low231.400	Vol376.27K
Open234.800	D1 Closing234.800	Amplitude4.94%
Mkt Cap21.13B	Tradable Cap21.13B	Total Shares90.54M
T/O89.01M	T/O Rate0.42%	Tradable Shares90.54M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"DUALITYBIO-B","latestPrice":233.4,"timestamp":1784871449321,"preClose":234.8,"halted":0,"volume":376266,"delay":0,"changeRate":-0.005962521294718933,"floatShares":90544200,"shares":90544200,"eps":-46.06333231389339,"marketStatus":"Trading","change":-1.4,"latestTime":"07-24 13:37:45","open":234.8,"high":243,"low":231.4,"amount":89007831,"amplitude":0.049404,"askPrice":233.4,"askSize":500,"bidPrice":233,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-36.887701696191215,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1784880600000},"marketStatusCode":2,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":234.8,"openAndCloseTimeList":[[1784856600000,1784865600000],[1784869200000,1784880000000]],"volumeRatio":0.561092,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09606/","defaultTab":"news","newsList":[{"id":"1104410900","title":"Movement Alert｜DotBio-B Falls 5.15% in Regular Trading, Biotech Sector Broadly Weakens After Prior Session Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1104410900","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104410900?lang=en_us&edition=fundamental","pubTime":"2026-07-21 10:17","pubTimestamp":1784600232,"startTime":"0","endTime":"0","summary":"On July 21, DotBio-B declined 5.15% in regular trading, trading at 230.2 HKD/share, with turnover of approximately HKD 54.22 million. The broader biotechnology sector showed widespread weakness, with...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162254238","title":"Hong Kong Market Analysis: Curse Lifted, Stimulus Resumes, Token Concept Stocks Soar","url":"https://stock-news.laohu8.com/highlight/detail?id=1162254238","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162254238?lang=en_us&edition=fundamental","pubTime":"2026-07-20 21:10","pubTimestamp":1784553010,"startTime":"0","endTime":"0","summary":"The Hong Kong stock market's performance has been commendable recently, having risen for three consecutive weeks. A key factor is the influx of incremental capital: the US has confirmed to China that...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","BK1618","LU1328277881.USD","BK4588","BK1517","LU0708995583.HKD","BK1163","LU1048588211.SGD","BK1109","BK1594","LU0072462343.USD","BK1538","LU0051755006.USD","LU1813983027.USD","VXUS","IE0034224299.USD","LU2543165471.USD","03317","BK1530","LU0052750758.USD","00268","BK1586","LU1023057109.AUD","BK1518","HK0000252160.HKD","BK1125","01898","BK1161","BK1155","03986","BK1178","BK1526","KCAI","LU0359201612.USD","LU0359201885.HKD","LU0456827905.SGD","BK1589","HK0000252152.HKD","LU0320764599.SGD","BK1613","HK0000500386.USD","BK1607","BK4585","LU0359202008.SGD","09606","LU0314109678.HKD","00991"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139325586","title":"Movement Alert｜DotBio-B Rises 7.07% in Regular Trading, DB-1310 Clinical Data Unveiled at ASCO and Partner Avenzo Completes Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1139325586","media":"Market Focus","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139325586?lang=en_us&edition=fundamental","pubTime":"2026-07-20 10:32","pubTimestamp":1784514760,"startTime":"0","endTime":"0","summary":"On July 20, DotBio-B rose 7.07% in regular trading, trading at HK$231.4 per share, with turnover of HK$122 million.On the news front, the company recently presented initial Phase I/IIa results for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174474978","title":"Movement Alert｜Duality Biotherapeutics Declines 5.99% in Regular Trading, Trading at HK$220.2","url":"https://stock-news.laohu8.com/highlight/detail?id=1174474978","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174474978?lang=en_us&edition=fundamental","pubTime":"2026-07-17 10:02","pubTimestamp":1784253754,"startTime":"0","endTime":"0","summary":"On July 17, Duality Biotherapeutics-B (09606.HK) fell 5.99% in regular trading, trading at HK$220.2 per share, with turnover of HK$53.05 million.Within the Biotechnology sector where Duality...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130433920","title":"Movement Alert｜DotBio Rises 5.12% in Regular Trading, A-Share IPO Enters Inquiry Stage Amid HK-to-A Return Wave","url":"https://stock-news.laohu8.com/highlight/detail?id=1130433920","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130433920?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:47","pubTimestamp":1784080068,"startTime":"0","endTime":"0","summary":"On July 15, DotBio-B (09606.HK) rose 5.12% in regular trading, trading at HK$233.4/share, with turnover of approximately HK$48.9 million.The rally comes amid sustained momentum from the company's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650150375","title":"Duality Biotherapeutics Insiders Sold CN¥89m Of Shares Suggesting Hesitancy","url":"https://stock-news.laohu8.com/highlight/detail?id=2650150375","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650150375?lang=en_us&edition=fundamental","pubTime":"2026-07-12 10:43","pubTimestamp":1783824233,"startTime":"0","endTime":"0","summary":"Many Duality Biotherapeutics, Inc. ( HKG:9606 ) insiders ditched their stock over the past year, which may be of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/duality-biotherapeutics-insiders-sold-cn89m-of-shares-sugges","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/duality-biotherapeutics-insiders-sold-cn89m-of-shares-sugges","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000252152.HKD","CN","HK0000500386.USD","HK0000252160.HKD","BK1161","LU2543165471.USD","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198039714","title":"Movement Alert｜Duality Biotherapeutics-B Rises 6.27% in Regular Trading, Soochow Securities Initiates with Buy Rating and HK$418.61 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1198039714","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198039714?lang=en_us&edition=fundamental","pubTime":"2026-07-10 09:48","pubTimestamp":1783648124,"startTime":"0","endTime":"0","summary":"On July 10, Duality Biotherapeutics-B (09606.HK) rose 6.27% in regular trading, trading at HK$215.2/share, with turnover of HK$35.54 million.The rally was driven by continued market reaction to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191425308","title":"Movement Alert｜Duality Biotherapeutics-B Rises 5.33% in Regular Trading, Soochow Securities Initiates with Buy Rating and HK$418.61 Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1191425308","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191425308?lang=en_us&edition=fundamental","pubTime":"2026-07-08 10:01","pubTimestamp":1783476070,"startTime":"0","endTime":"0","summary":"On July 8, Duality Biotherapeutics-B rose 5.33% in regular trading, trading at HK$222.0/share, with turnover of approximately HK$74.52 million.On the news front, Soochow Securities initiated coverage...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108116756","title":"Movement Alert｜Duality Biotherapeutics-B Falls 5.07% in Regular Trading, Biotech Sector Faces Broad Profit-Taking Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1108116756","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108116756?lang=en_us&edition=fundamental","pubTime":"2026-07-07 15:19","pubTimestamp":1783408787,"startTime":"0","endTime":"0","summary":"On July 7, Duality Biotherapeutics-B declined 5.07% in regular trading, trading at 213.4 HKD/share, with turnover of HKD 388 million. The pullback came after the stock posted substantial gains in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177976671","title":"Movement Alert｜Duality Biotherapeutics-B Rises 9.01% in Regular Trading, STAR Market IPO Status Upgraded to Inquired Amid ADC Sector Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1177976671","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177976671?lang=en_us&edition=fundamental","pubTime":"2026-07-06 09:51","pubTimestamp":1783302687,"startTime":"0","endTime":"0","summary":"On July 6, Duality Biotherapeutics-B rose 9.01% in regular trading, trading at HK$232.0/share, with turnover of HK$105 million. The rally was driven by the company's STAR Market IPO review status...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160793891","title":"Movement Alert｜Duality Biotherapeutics-B Rises 6.31% in Regular Trading, ADC Sector Breakthroughs and STAR Market IPO Filing Continue to Drive Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1160793891","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160793891?lang=en_us&edition=fundamental","pubTime":"2026-07-03 09:41","pubTimestamp":1783042890,"startTime":"0","endTime":"0","summary":"On July 3, Duality Biotherapeutics-B rose 6.31% in regular trading, trading at HKD 216.8/share, with turnover of approximately HKD 106 million. This follows a 15.01% surge the prior session.On the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182763549","title":"Market Analysis: Meta's AI Compute Sale Not a Bearish Signal; Healthcare Stocks Surge on Multiple Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1182763549","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182763549?lang=en_us&edition=fundamental","pubTime":"2026-07-02 20:06","pubTimestamp":1782994017,"startTime":"0","endTime":"0","summary":"The market's reaction to Meta Platforms, Inc.'s (META) move to sell excess AI computing capacity was unexpected, causing a significant sell-off in global AI-related stocks. While A-shares suffered...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","AMZN","HK0000252152.HKD","SG9999003461.SGD","LU1951186391.HKD","IE00B5MMRT66.SGD","SOCL","LU1008478684.HKD","HK0000165453.HKD","AGIX","LU1960683339.HKD","HK0000252160.HKD","IE0008369823.USD","06693","IE00B031HY20.USD","BK1198","LU0196878994.USD","GOOG","YMAG","LU2039709279.SGD","LU0314109678.HKD","BK1544","06990","AIPO","BK1592","02099","LU1969619763.USD","159938","BK1161","SG9999004220.SGD","SG9999001093.SGD","LU0315179316.USD","LU1152091754.HKD","BK1583","LU1226288253.USD","META","09606","TSLA","LU1993786604.SGD","LU1328277881.USD","BK4585","IE00BZ08YR35.GBP","LU1807302812.USD","AAPL","LU1152091168.USD","BK1521","MSFT","VXUS","BK1574","NVDA","LU1226287792.SGD","BK1515","01093","LU0880133367.SGD","LU0326950275.SGD","IE00BZ08YS42.EUR","LU0072913022.USD","BK1191","ARTY","LU1226287875.USD","IE00BZ08YT58.USD","LU0501845795.SGD","09995","LU0067412154.USD","LU0140636845.USD","09939","HK0000500386.USD","LU2328871848.SGD","MAGY","LU2543165471.USD","BULZ","IE0008368742.USD","LU1226288170.HKD","IE00B543WZ88.USD","LU1226287529.USD","BK4588","LU1813983027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192849276","title":"Movement Alert｜Duality Biotherapeutics-B Rises 15.01% in Regular Trading, ADC Sector Breakthrough and Biotech Rebound Drive Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1192849276","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192849276?lang=en_us&edition=fundamental","pubTime":"2026-07-02 10:21","pubTimestamp":1782958918,"startTime":"0","endTime":"0","summary":"On July 2, Duality Biotherapeutics-B rose 15.01% in regular trading, trading at HKD 208.2 per share, with turnover of HKD 209 million.On the news front, the domestic ADC sector has achieved...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130031573","title":"Movement Alert｜Duality Biotherapeutics-B Rises 5.65% in Regular Trading, Buyback Action Signals Management Confidence Amid Biotech Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1130031573","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130031573?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:57","pubTimestamp":1782698254,"startTime":"0","endTime":"0","summary":"On June 29, Duality Biotherapeutics-B rose 5.65% in regular trading, trading at HK$173.1/share, with turnover of HK$31.49 million.On the news front, the company disclosed on June 29 that it...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160997264","title":"DualityBio-B (09606) Allocates HK$11.99 Million for Share Buyback on June 26","url":"https://stock-news.laohu8.com/highlight/detail?id=1160997264","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160997264?lang=en_us&edition=fundamental","pubTime":"2026-06-29 08:40","pubTimestamp":1782693629,"startTime":"0","endTime":"0","summary":"DualityBio-B (09606) has announced a share repurchase transaction.The company executed a buyback of 73,800 shares on June 26, 2026, utilizing approximately HK$11.99 million in capital.The repurchase price for the shares ranged between HK$161.2 and HK$164.4 per share.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","HK0000252160.HKD","LU2543165471.USD","BK1161","09606","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647413303","title":"Duality Biotherapeutics Files HKEX Next-day Disclosure Return on Share Repurchase for Treasury Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2647413303","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647413303?lang=en_us&edition=fundamental","pubTime":"2026-06-29 08:15","pubTimestamp":1782692142,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics files HKEX next-day disclosure return on share repurchase for treasury sharesDuality Biotherapeutics repurchased 73,800 shares on June 26, 2026 for treasury, not cancellation.B","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDLcltGV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","HK0000252152.HKD","09606","BK1161","HK0000500386.USD","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146157480","title":"DualityBio-B Announces Appointment of Leung Chi Kit as Joint Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1146157480","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146157480?lang=en_us&edition=fundamental","pubTime":"2026-06-26 22:34","pubTimestamp":1782484459,"startTime":"0","endTime":"0","summary":"The board of DUALITYBIO-B (09606) has announced a change in its company secretarial and authorized representative positions.Ms. Tsang Wing Man has resigned from her roles as the company's Joint...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","HK0000500386.USD","LU2543165471.USD","HK0000252152.HKD","HK0000252160.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150440135","title":"Duality Biotherapeutics Announces Company-Secretary Transition, Secures New HKEX Waiver, Relocates Hong Kong Office","url":"https://stock-news.laohu8.com/highlight/detail?id=1150440135","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150440135?lang=en_us&edition=fundamental","pubTime":"2026-06-26 22:24","pubTimestamp":1782483868,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. disclosed a series of corporate administration changes effective 26 June 2026. Leadership Transition   •  Joint Company Secretary, Authorized Representative and Process...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192012461","title":"DualityBio grants 283,500 RSUs worth HK$46.16 million to 38 employees under 2025 Share Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1192012461","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192012461?lang=en_us&edition=fundamental","pubTime":"2026-06-26 22:24","pubTimestamp":1782483866,"startTime":"0","endTime":"0","summary":"Hong Kong, 26 Jun 2026 — Duality Biotherapeutics (DualityBio) disclosed that its Board, or delegated authority, approved the issuance of 283,500 restricted share units (RSUs) to 38 Group employees on...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166270030","title":"Duality Biotherapeutics Clears All AGM Resolutions, Secures Mandates for Share Repurchase and Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=1166270030","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166270030?lang=en_us&edition=fundamental","pubTime":"2026-06-26 22:23","pubTimestamp":1782483834,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. held its annual general meeting on 26 June 2026, with shareholders approving every item on the agenda by poll. Key outcomes: • Financial Statements Adopted      – The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dualitybiologics.com","stockEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":0.3273},{"period":"3month","weight":-0.1975},{"period":"6month","weight":-0.2983},{"period":"1year","weight":-0.2602},{"period":"ytd","weight":-0.2126}],"compareEarnings":[{"period":"1week","weight":0.0081},{"period":"1month","weight":0.0803},{"period":"3month","weight":-0.0295},{"period":"6month","weight":-0.0575},{"period":"1year","weight":-0.0128},{"period":"ytd","weight":-0.0164}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Duality Biotherapeutics Inc is an investment holding company principally engaged in clinical-stage biopharmaceuticals. The Company is dedicated to the development of antibody-drug conjugate (ADC) innovative therapeutics to treat cancer and autoimmune diseases. The Company's primary drug product candidates include DB-1303/BNT323, DB-1311/BNT324, DB-1310, DB-1305/BNT325, DB-1419 and DB-2304. The Company's products are mainly used for the targeted treatment of endometrial cancer (EC), breast cancer (BC), small-cell lung cancer (SCLC), castration-resistant prostate cancer (CRPC), esophageal squamous cell carcinoma (ESCC), as well as head and neck squamous cell carcinoma (HNSCC). The Company principally conducts its businesses in domestic and overseas markets.","exchange":"SEHK","name":"DUALITYBIO-B","nameEN":"DUALITYBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DUALITYBIO-B(09606),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest DUALITYBIO-B(09606) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"DUALITYBIO-B,09606,DUALITYBIO-B股票,DUALITYBIO-B股票老虎,DUALITYBIO-B股票老虎国际,DUALITYBIO-B行情,DUALITYBIO-B股票行情,DUALITYBIO-B股价,DUALITYBIO-B股市,DUALITYBIO-B股票价格,DUALITYBIO-B股票交易,DUALITYBIO-B股票购买,DUALITYBIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DUALITYBIO-B(09606),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest DUALITYBIO-B(09606) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}